Latest progress of docetaxel clinical pharmacokinetics Health Articles | March 29 http://www.cheapnikeairfoampositeone.com/ , 2012 Docetaxel belongs to taxane anticancer drugs. It has an anti-tumor effect by inducing microtubule stability and destruction of the microtubule network dynamics. Docetaxel has shown a broad-spectrum anti-tumor activity in preclinical models and clinical treatment.
It is found in the reactions of many types of diseases, including advanced breast cancer and non-small cell lung cancer. Docetaxel pharmacokinetics and metabolism are very complex. In recent years, these scientists have been studied in the subject.
Docetaxel gets a range of metabolic transformation by cytochrome isoenzyme, resulting in formations of several pharmacological oxidation products without activity Docetaxel elimination of the route depends on the degree of presence of drug transporters, especially present in the bile tubule membrane glycoprotein. Adjust the drug elimination process, through metabolic breakdown or excretion of the ways to achieve. Docetaxel regimen of the individual strategy is based on ongoing cytochrome expression in the chia seed process is the difference of the phenotype or genotype may eventually make this drug a more selective chemotherapeutic use.
Anticancer drug docetaxel gets microtubule stabilization by aggregometry and inhibition of tubulin depolymerization, thereby undermining the dynamics of the microtubule network. Docetax ariety treatments of active cancer include breast Wolesale Nike Air Foamposite One , lung, head and neck,